Eman Khaled, Juhi Godara, G. Alrais, Asra'a Alnakeb
This comprehensive narrative review elucidates the complexities surrounding menopausal hormone therapy (MHT), encompassing diverse symptom management strategies and associated risks. It explores the dynamic landscape of hormonal and non-hormonal approaches, integrating recent primary evidence and updated recommendations from specialized medical societies. Menopause, a critical phase in women's lives, is examined through its multifaceted physiological changes and the impact of MHT on symptomatology and long-term health outcomes. Additionally, the review delves into alternative therapies, emphasizing personalized care and tailored interventions for managing menopausal symptoms effectively
{"title":"MENOPAUSAL HORMONE THERAPY AND SYMPTOM MANAGEMENT: A COMPREHENSIVE REVIEW","authors":"Eman Khaled, Juhi Godara, G. Alrais, Asra'a Alnakeb","doi":"10.36106/ijsr/3220352","DOIUrl":"https://doi.org/10.36106/ijsr/3220352","url":null,"abstract":"This comprehensive narrative review elucidates the complexities surrounding menopausal hormone therapy (MHT), encompassing diverse\u0000symptom management strategies and associated risks. It explores the dynamic landscape of hormonal and non-hormonal approaches, integrating\u0000recent primary evidence and updated recommendations from specialized medical societies. Menopause, a critical phase in women's lives, is\u0000examined through its multifaceted physiological changes and the impact of MHT on symptomatology and long-term health outcomes.\u0000Additionally, the review delves into alternative therapies, emphasizing personalized care and tailored interventions for managing menopausal\u0000symptoms effectively","PeriodicalId":14358,"journal":{"name":"International journal of scientific research","volume":"14 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141134151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The Enhanced Recovery After Surgery (ERAS) route was created to help patients following major surgery recover more quickly. Three crucial elements include the preoperative, intraoperative, and postoperative regimens.Early eating, opioid-free multimodal pain treatment, and euvolemia are just a few of the elements that make up enhanced recovery protocols, which all work together to speed postoperative recovery. In order to optimize patient care, pre- and post-habilitation are crucial. The results for patients signicantly improved once the ERAS was implemented, and the overall cost of treatment decreased. Evidence-based medicine is the foundation of the ERAS. In this review, we summarized the most recent data on ERAS and how it benets the patient.
{"title":"ENHANCED RECOVERY AFTER SURGERY IN GYNECOLOGY","authors":"Hala El Sayed Ali Hassan","doi":"10.36106/ijsr/3520436","DOIUrl":"https://doi.org/10.36106/ijsr/3520436","url":null,"abstract":"The Enhanced Recovery After Surgery (ERAS) route was created to help patients following major surgery recover more quickly. Three crucial\u0000elements include the preoperative, intraoperative, and postoperative regimens.Early eating, opioid-free multimodal pain treatment, and\u0000euvolemia are just a few of the elements that make up enhanced recovery protocols, which all work together to speed postoperative recovery. In\u0000order to optimize patient care, pre- and post-habilitation are crucial. The results for patients signicantly improved once the ERAS was\u0000implemented, and the overall cost of treatment decreased. Evidence-based medicine is the foundation of the ERAS. In this review, we summarized\u0000the most recent data on ERAS and how it benets the patient.","PeriodicalId":14358,"journal":{"name":"International journal of scientific research","volume":"47 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141142195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yugam Rajeshkumar Oza, H. M. Joshi, Sameeha Fatima Khan, Amna Shahid Bilal, Ali Zeeshan Murtuza, Vidhi Mashru
Intestinal failure associated with liver disease (IFALD) is an intricate illness having the prevalence of 40-60% in paediatric population and 15-40% in adults [1]. The diseases corresponding with liver include cholestasis, gall bladder disease, steatohepatitis, and biliary cirrhosis [1]. Since IFALD has a complicated etiology there are many factors causing it but parenteral administration (PN) remains the key reason. Each patient of a different age group presents with varying symptoms and signs, so the treatment strategy is tailored accordingly. This review encompasses the risk factors causing IFALD along with the intricate pathogenesis, the changes that can be bought in our diet to prevent it from occurring and last most importantly the management techniques along with the line of treatment.
{"title":"FROM BOWELS TO BILIRUBIN UNRAVELING THE MECHANISM OF INTESTINAL FAILURE ASSOCIATED LIVER DISEASE: A NARRATIVE REVIEW","authors":"Yugam Rajeshkumar Oza, H. M. Joshi, Sameeha Fatima Khan, Amna Shahid Bilal, Ali Zeeshan Murtuza, Vidhi Mashru","doi":"10.36106/ijsr/8208926","DOIUrl":"https://doi.org/10.36106/ijsr/8208926","url":null,"abstract":"Intestinal failure associated with liver disease (IFALD) is an intricate illness having the prevalence of 40-60% in paediatric population and 15-40%\u0000in adults [1]. The diseases corresponding with liver include cholestasis, gall bladder disease, steatohepatitis, and biliary cirrhosis [1]. Since IFALD\u0000has a complicated etiology there are many factors causing it but parenteral administration (PN) remains the key reason. Each patient of a different\u0000age group presents with varying symptoms and signs, so the treatment strategy is tailored accordingly. This review encompasses the risk factors\u0000causing IFALD along with the intricate pathogenesis, the changes that can be bought in our diet to prevent it from occurring and last most\u0000importantly the management techniques along with the line of treatment.","PeriodicalId":14358,"journal":{"name":"International journal of scientific research","volume":"24 32","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141136861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Dengue a vector borne disease considered hazard to public health. Diagnosis is by dengue specic antigen and antibody detection. Decrease in platelet count consider as warning sign in dengue positive cases. Hence this study was done to correlate various dengue parameter and platelet count. Material and Methods: A Retrospective analytical study conducted from period of September 2022- September 2023.A total of 1670 serum samples tested for dengue using ICTkit , 82 samples were tested positive. Platelet count recorded for all the cases. Results: 1670 serum sample tested for dengue, 82 sample tested positive for dengue antigen or antibody by ICT based test. Thrombocytopenia (platelet count <